Arjuna Capital Sells 182 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Arjuna Capital reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,374 shares of the healthcare conglomerate’s stock after selling 182 shares during the period. UnitedHealth Group accounts for about 1.4% of Arjuna Capital’s holdings, making the stock its 20th biggest position. Arjuna Capital’s holdings in UnitedHealth Group were worth $5,481,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. Tealwood Asset Management Inc. bought a new stake in UnitedHealth Group during the third quarter valued at approximately $2,905,000. Asset Planning Services Inc. LA ADV lifted its holdings in shares of UnitedHealth Group by 1.2% in the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after acquiring an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of UnitedHealth Group by 13.7% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after acquiring an additional 3,006 shares during the last quarter. Americana Partners LLC lifted its holdings in shares of UnitedHealth Group by 10.8% in the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after acquiring an additional 1,984 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 14.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock worth $5,072,000 after acquiring an additional 1,283 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.8 %

Shares of NYSE:UNH traded down $4.82 during midday trading on Wednesday, reaching $609.85. The company’s stock had a trading volume of 406,898 shares, compared to its average volume of 3,881,150. The firm has a 50 day moving average of $582.95 and a 200-day moving average of $547.62. The firm has a market capitalization of $561.23 billion, a P/E ratio of 40.07, a PEG ratio of 1.84 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.56 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on UNH. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Cantor Fitzgerald upped their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Royal Bank of Canada lowered their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Finally, Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.